Making Intracellular Biologics a Reality

Entrada Therapeutics is a biotechnology company dedicated to transforming the treatment of devastating diseases through the intracellular delivery of biologics

Discover

Discover the science behind our approach

Meet

Meet the leadership team at Entrada Therapeutics

Learn

Learn about the work we are doing

News & Press Releases

Entrada Therapeutics Appoints Nathan Dowden as Chief Operating Officer

Entrada Therapeutics, a biotechnology company dedicated to transforming the treatment of devastating diseases through the intracellular delivery of biologics, today announced the appointment of Nathan J. Dowden as Chief Operating Officer.

Read more
November 04, 2019

Entrada Therapeutics Appoints John F. Crowley to Board of Directors

BOSTON, Mass., June 19, 2019 – Entrada Therapeutics, a biotechnology company dedicated to transforming the treatment of devastating diseases through the intracellular delivery of biologics, today announced the appointment of John F. Crowley as an independent board member to the Company’s Board of Directors.

Read more
June 19, 2019

Entrada Therapeutics Appoints Mario Saltarelli, M.D., Ph.D., as Chief Medical Officer

BOSTON, Mass., March 19, 2019 – Entrada Therapeutics, a biotechnology company dedicated to transforming the treatment of devastating diseases through the intracellular delivery of biologics, today announced the appointment of Mario Saltarelli, M.D., Ph.D., as Chief Medical Officer.

Read more
March 19, 2019
More news